nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone Propionate—Anger—Varenicline—nicotine dependence	0.0796	0.112	CcSEcCtD
Testosterone Propionate—Endocrine disorder—Varenicline—nicotine dependence	0.0343	0.0482	CcSEcCtD
Testosterone Propionate—Aggression—Varenicline—nicotine dependence	0.0324	0.0454	CcSEcCtD
Testosterone Propionate—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0226	0.0788	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0224	0.0777	CbGpPWpGaD
Testosterone Propionate—Libido decreased—Varenicline—nicotine dependence	0.0223	0.0313	CcSEcCtD
Testosterone Propionate—Increased appetite—Varenicline—nicotine dependence	0.022	0.0308	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.0206	0.029	CcSEcCtD
Testosterone Propionate—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.0205	0.0288	CcSEcCtD
Testosterone Propionate—Irritability—Varenicline—nicotine dependence	0.0197	0.0277	CcSEcCtD
Testosterone Propionate—Liver function test abnormal—Varenicline—nicotine dependence	0.0191	0.0268	CcSEcCtD
Testosterone Propionate—Breast disorder—Varenicline—nicotine dependence	0.0187	0.0262	CcSEcCtD
Testosterone Propionate—CYP17A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0184	0.0639	CbGpPWpGaD
Testosterone Propionate—Erectile dysfunction—Varenicline—nicotine dependence	0.0164	0.0231	CcSEcCtD
Testosterone Propionate—Weight increased—Varenicline—nicotine dependence	0.0162	0.0228	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Varenicline—nicotine dependence	0.015	0.0211	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Varenicline—nicotine dependence	0.0141	0.0198	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Varenicline—nicotine dependence	0.014	0.0197	CcSEcCtD
Testosterone Propionate—Urethral disorder—Varenicline—nicotine dependence	0.014	0.0197	CcSEcCtD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.0132	0.0458	CbGpPWpGaD
Testosterone Propionate—Angiopathy—Varenicline—nicotine dependence	0.013	0.0182	CcSEcCtD
Testosterone Propionate—Immune system disorder—Varenicline—nicotine dependence	0.0129	0.0181	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Varenicline—nicotine dependence	0.0129	0.0181	CcSEcCtD
Testosterone Propionate—Mental disorder—Varenicline—nicotine dependence	0.0125	0.0176	CcSEcCtD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.0125	0.0434	CbGpPWpGaD
Testosterone Propionate—Malnutrition—Varenicline—nicotine dependence	0.0124	0.0175	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Varenicline—nicotine dependence	0.0115	0.0162	CcSEcCtD
Testosterone Propionate—Malaise—Varenicline—nicotine dependence	0.0112	0.0157	CcSEcCtD
Testosterone Propionate—COMT—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0108	0.0376	CbGpPWpGaD
Testosterone Propionate—Hypertension—Varenicline—nicotine dependence	0.0107	0.0151	CcSEcCtD
Testosterone Propionate—Myalgia—Varenicline—nicotine dependence	0.0106	0.0149	CcSEcCtD
Testosterone Propionate—Arthralgia—Varenicline—nicotine dependence	0.0106	0.0149	CcSEcCtD
Testosterone Propionate—Anxiety—Varenicline—nicotine dependence	0.0106	0.0148	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.0105	0.0148	CcSEcCtD
Testosterone Propionate—Discomfort—Varenicline—nicotine dependence	0.0105	0.0147	CcSEcCtD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0103	0.036	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—CYP2A7—nicotine dependence	0.0102	0.0354	CbGpPWpGaD
Testosterone Propionate—Oedema—Varenicline—nicotine dependence	0.0101	0.0142	CcSEcCtD
Testosterone Propionate—COMT—Neuronal System—CHRNB3—nicotine dependence	0.0101	0.0351	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—CYP2A7—nicotine dependence	0.01	0.0349	CbGpPWpGaD
Testosterone Propionate—Nervous system disorder—Varenicline—nicotine dependence	0.00995	0.014	CcSEcCtD
Testosterone Propionate—Skin disorder—Varenicline—nicotine dependence	0.00986	0.0138	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—CYP2A7—nicotine dependence	0.00975	0.0339	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00962	0.0335	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—CHRNA6—nicotine dependence	0.00957	0.0333	CbGpPWpGaD
Testosterone Propionate—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00925	0.013	CcSEcCtD
Testosterone Propionate—Insomnia—Varenicline—nicotine dependence	0.00918	0.0129	CcSEcCtD
Testosterone Propionate—Dyspnoea—Varenicline—nicotine dependence	0.00905	0.0127	CcSEcCtD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00903	0.0314	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00876	0.0123	CcSEcCtD
Testosterone Propionate—Fatigue—Varenicline—nicotine dependence	0.00875	0.0123	CcSEcCtD
Testosterone Propionate—Pain—Varenicline—nicotine dependence	0.00868	0.0122	CcSEcCtD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00865	0.0301	CbGpPWpGaD
Testosterone Propionate—Feeling abnormal—Varenicline—nicotine dependence	0.00836	0.0117	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Varenicline—nicotine dependence	0.0083	0.0116	CcSEcCtD
Testosterone Propionate—Urticaria—Varenicline—nicotine dependence	0.00806	0.0113	CcSEcCtD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00805	0.028	CbGpPWpGaD
Testosterone Propionate—Abdominal pain—Varenicline—nicotine dependence	0.00802	0.0113	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Varenicline—nicotine dependence	0.00748	0.0105	CcSEcCtD
Testosterone Propionate—Asthenia—Varenicline—nicotine dependence	0.00728	0.0102	CcSEcCtD
Testosterone Propionate—Pruritus—Varenicline—nicotine dependence	0.00718	0.0101	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00712	0.0248	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Varenicline—nicotine dependence	0.00694	0.00975	CcSEcCtD
Testosterone Propionate—COMT—Neuronal System—GABRA4—nicotine dependence	0.00692	0.0241	CbGpPWpGaD
Testosterone Propionate—Dizziness—Varenicline—nicotine dependence	0.00671	0.00942	CcSEcCtD
Testosterone Propionate—COMT—Neuronal System—CHRNB4—nicotine dependence	0.00663	0.0231	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00656	0.0228	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00647	0.0225	CbGpPWpGaD
Testosterone Propionate—Vomiting—Varenicline—nicotine dependence	0.00645	0.00906	CcSEcCtD
Testosterone Propionate—Rash—Varenicline—nicotine dependence	0.0064	0.00898	CcSEcCtD
Testosterone Propionate—Dermatitis—Varenicline—nicotine dependence	0.00639	0.00897	CcSEcCtD
Testosterone Propionate—Headache—Varenicline—nicotine dependence	0.00636	0.00892	CcSEcCtD
Testosterone Propionate—COMT—Neuronal System—CHRNA5—nicotine dependence	0.00616	0.0214	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP2A7—nicotine dependence	0.0061	0.0212	CbGpPWpGaD
Testosterone Propionate—Nausea—Varenicline—nicotine dependence	0.00603	0.00846	CcSEcCtD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00602	0.0209	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00577	0.0201	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00524	0.0182	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—CHRNA3—nicotine dependence	0.00503	0.0175	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00475	0.0165	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—CHRNB2—nicotine dependence	0.00442	0.0154	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00431	0.015	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—CHRNA4—nicotine dependence	0.00402	0.014	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—CCAR1—nicotine dependence	0.00234	0.00815	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYP2A7—nicotine dependence	0.00174	0.00606	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYP2A7—nicotine dependence	0.00167	0.0058	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP2A7—nicotine dependence	0.00104	0.00363	CbGpPWpGaD
